Practitioners of meditation have long believed in its ability to treat stress and chronic disease. The physiological basis of this belief has never been fully described, but as current research continues to reveal the intricacies of neuro-endocrine pathways, meditation, yoga, and other mind-body therapies are considered to be promising options in the treatment of diabetes.

The prevalence of diabetes is increasing dramatically worldwide.1  Negative effects of physiological and emotional stress on blood glucose control have been described in the literature.2,3 Mind-body therapies, such as meditation, yoga, qi-gong, and other relaxation techniques, have been studied in diabetes as a means of decreasing stress-related hyperglycemia.48 The objective of many mind-body therapies is to facilitate attainment of a physiological state that counteracts the stress response and develops into a permanent set of traits among practitioners.

Physiological and emotional stress activate neuro-endocrine and sympathetic pathways via the hypothalamic-pituitary-adrenal axis and medullary adrenal sympathetic system.9,10 Circulating catecholamines and glucocorticoids affect the structure and function of a variety of tissues and induce inflammatory cytokines that lead to increased glucagon production and decreased uptake and disposal of glucose in peripheral muscles.11 Cytokines, primarily interleukin 6, have been strongly implicated in oxidative stress and inflammatory processes that lead to insulin resistance and vascular complications.1113 

The relaxation response promotes regulation of cortisol and other stress hormones.14 Structured programs of meditation, such as Transcendental Meditation and Mindfulness-Based Stress Reduction (MBSR), train participants in focused attention and diaphragmatic breathing to invoke this response. Other relaxation therapies involve progressive muscle relaxation, biofeedback, and a variety of behavioral stress management techniques, such as guided imagery.

Yoga is a traditional Indian practice that includes diaphragmatic breathing and asanas (body postures that promote physical comfort and mental composure). Yoga experts believe that some asanas exert positive effects on various endocrine glands.15 Qi-gong is an ancient Chinese form of “moving meditation”similar to t'ai chi that combines slow diaphragmatic breathing with spiral and circular body movements.16 

K.M. is a 57-year-old black woman with hypertension, hyperlipidemia, and a 5-year history of type 2 diabetes treated with metformin and a sulfonylurea who presents for follow-up of diabetes. Her A1C has been > 7.5% for the past year. Her serum creatinine is noted to have increased to 1.6 mg/dl since the last appointment with her primary care provider. She complains of a lot of stress at home. She has been intolerant of thiazolidinedione medications because of edema and weight gain. She has not been able to lose weight despite multiple attempts at dieting and has difficulty exercising because of pain related to osteoarthritis in her hips and knees. Her health insurance does not cover many newer diabetes medications, and she cannot afford high-cost medications. She is fearful of needles and wants to avoid injections.

Physical exam reveals a BMI of 32 kg/m2 and blood pressure of 138/84 mmHg. Acanthosis nigricans is noted at the skin folds of her posterior neck. Her waist circumference is 40 inches. Her heart and lung examination are normal, and her abdomen is obese and nontender without masses. The remainder of her physical examination is unremarkable. Pertinent laboratory values include A1C of 7.8%, fasting plasma glucose (FPG) of 168 mg/dl, and serum creatinine of 1.6 mg/dl.

Are there any cost-effective, nonpharmacological therapies in addition to weight loss and exercise that may help improve glycemic control in adults with diabetes?

  • Population: adults with diabetes

  • Intervention: meditative therapies for glycemic control

  • Comparison: nonmeditative therapies for glycemic control

  • Outcomes of interest: A1C and FPG

To conduct an integrated review of the literature, three databases(Medline, CINAHL, and AMED) were queried using the search terms meditation,yoga, relaxation techniques, breathing exercises, diabetes type 1 or type 2,hyperinsulinism, and hemoglobin A, glycosylated. This search yielded 20 citations written in English between 1974 and 2007. Articles written in English, using adult samples, and published after 1985 were reviewed. Before 1985, most of the work done in this area was qualitative or anecdotal. Articles were retrieved from the Health Science Library System at the University of Pittsburgh in Pennsylvania.

The search was limited to two dependent variables: A1C and FPG. A1C is an accepted measure of glycemic control in diabetes that estimates the average blood glucose level from the previous 3 months. The American Diabetes Association (ADA) recommends maintaining an A1C < 7% to decrease the risk of microvascular complications. FPG provides a measure of glycemic control in terms of pancreatic ⊠-cell function and insulin resistance.16 

All study interventions took place in outpatient settings without interruption or change in the participants' current diabetes therapy. Improvements in A1C consistently correlated with improvements in FPG. No adverse effects were reported in any of the studies. All but one study were performed in adults with type 2 diabetes, and one study was done in adults with type 1 diabetes. Additionally, all but one of the studies used a group intervention; however, possible cohort effects were not addressed by the authors. A comparison of the studies is found in Table 1.

Table 1.

Comparison of Studies Included in Integrative Review

Comparison of Studies Included in Integrative Review
Comparison of Studies Included in Integrative Review

Three observational studies performed in India using multi-modality yoga interventions observed positive improvements in glycemic control, prompting the investigators to conclude that the physiological mechanism should be further explored.47 A 2007 prospective observational pilot study on MBSR in type 2 diabetes demonstrated decreased A1C and psychological distress independent of weight loss and lifestyle modification.17 This was the first study to investigate MBSR in a cohort of individuals with diabetes.

Secondary analysis of a randomized controlled trial (RCT) of 60 adults with type 2 diabetes was performed by Elder et al. using whole-systems analysis to evaluate a traditional multi-modality Indian Ayurvedic intervention protocol that incorporated daily meditation. The Vedic intervention was associated with decreased A1C and mean FPG only in participants whose baseline A1C was >6.5%.18  The results of this study were confounded by the other independent variables that included exercise, diet, and an herbal supplement.

Five other small RCTs showed trends toward positive improvements in A1C and FPG.7,8,1921 Control groups were variable and often included a second intervention, such as general health education, diabetes education, or exercise. A South African study that compared an intervention of education plus aerobic exercise to one of education plus relaxation therapy in Black African women showed small but similar improvements in A1C in both groups, which the authors attributed to study effect.20 

Studies of relaxation techniques with and without biofeedback had mixed results. Surwit et al. studied 108 subjects with type 2 diabetes for 1 year following a five-session group intervention of relaxation therapy plus diabetes education. There was a 0.5% reduction in A1C relative to control subjects, with 32% of the treatment group having a ≥ 1% reduction in A1C compared to 12% of control subjects.21 Reductions in A1C of as little as 0.6% have been associated with a significant reduction in risk of complications in type 2 diabetes.22 

Another study of relaxation therapy plus biofeedback demonstrated improved glycemic control that was sustained for 3 months and was associated with decreased depression and anxiety scores.19  However,a Swedish study of relaxation therapy in adults with type 1 diabetes failed to show an improvement in A1C despite improvement in mood.23  Similar findings were reported in a RCT of relaxation therapy plus biofeedback in which there was no improvement in FPG or other measures of glucose tolerance despite reductions in psychological and physiological stress.24 

Improvements in A1C with qi-gong were associated with improved mood and decreased C-peptide.8  The authors suggest that the observed reduction in C-peptide may suggest an underlying mechanism of decreased insulin resistance with qi-gong.

Based on the ADA evidence grading system for clinical practice recommendations, in which A is clear evidence from RTCs, B is supportive evidence from well-conducted cohort studies, C is from poorly controlled studies, and E is from expert consensus or clinical experience, four studies met criteria for level B and one study met criteria for level C. Although seven studies met most of the criteria for level A, none were large multi-center trials. All the RCTs reviewed had relatively small sample sizes and lacked scientific rigor, limiting their ability to make generalizable conclusions but provided convincing evidence for further inquiry. Four of eight RCTs reviewed for this article compared the effects of meditative therapies to those of usual care using conventional treatment regimens. Four others were confounded by additional nonmeditative interventions. Larger RCTs that investigate the mechanisms of action and compare effects of specific mind-body interventions on diabetes control are warranted.

Because K.M.'s serum creatinine had increased above 1.4 mg/dl, metformin was discontinued. Her sulfonylurea dose was increased. She was referred to a registered dietitian for medical nutrition therapy and was advised to enroll in a yoga class being offered at the YWCA in her neighborhood. She was asked to return for follow-up in 3 months. If her A1C remains > 7%, further adjustments to her diabetes medication regimen will be considered.

There are data to suggest that mind-body therapies may have an overall positive effect on glucose control. However, there is currently no conclusive evidence to support this hypothesis. No adverse effects were reported in any of the studies that were reviewed. Based on these studies, it appears that yoga, meditation, qi-gong, and relaxation therapy are safe techniques that may be of benefit in the treatment of diabetes but require further study.

Meditation, yoga, and other mind-body therapies are becoming more popular and accessible through local health clubs and wellness centers. These therapies may represent cost-effective self-care strategies for improving glucose control through regulation of neuro-endocrine processes that impair glucose metabolism. Until more research is available and the effects of these techniques are more clearly defined, mind-body therapies could be recommended only as potentially helpful adjuncts to conventional diabetes therapy.

Editor's note: The articles published in this department present patient cases using an evidence-based practice framework presented with“PICO” components: population, intervention, comparison, and outcome; a description of the search strategy employed for the integrative review; a summary of the results and critical appraisal of the search; and an evaluation of the scientific and medical evidence base for recommendations.

Monica M. DiNardo, MSN, CRNP, CDE, is a pre-doctoral student at the University of Pittsburgh School of Nursing in Pennsylvania.

1.
World Health Organisation, Diabetes Unit: Did you know? [article online] Available from http://www.idf.org/home/index.cfm?unode=3B96906B-C026-2FD3-87B73F80BC22682A. Accessed 21 April 2008
2.
Bacha F, Saad R,Gungor N, Arslanian SA: Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.
Diabetes Care
27
:
547
–552,
2004
3.
deGroot M, Jackson AM, Samson JA, Welch G: Glycemic control and major depression in patients with type1 and type2 diabetes.
J Psychosom Res
56
:
425
–435,
1999
4.
Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP: Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients.
J Assoc Phys India
52
:
203
–206,
2004
5.
Bijlani RL,Vempati RP, Yadav RK, Ray RB, Gupta V, Sharma R, Mehta N, Mahapatra SC: A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus.
J Alt Complement Med
11
:
267
–274,
2005
6.
Malhotra V, Singh S, Tandon OP, Sharma SB: The beneficial effect of yoga in diabetes.
Nepal Med Coll J
7
:
145
–147,
2005
7.
Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP: Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome.
Diabetes Res Clin Pract
78
:
9
–10,
2007
8.
Tsujiuchi T,Kumano H, Yoshiuchi K, He D, Tsujiuchi Y, Kuboki T, Suematsu H, Hirao K. The effect of qi-gong relaxation exercise on the control of type 2 diabetes mellitus: a randomized controlled trial.
Diabetes Care
25
:
241
–242,
2002
9.
Selye H: A syndrome produced by diverse nocuous agents.
Nature
138
:
32
,
1936
10.
Goldstein DS,Klopin JK: Evolution of concepts of stress.
Stress
10
:
109
–120,
2007
11.
Black PH: The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X.
Brain Behav Immun
17
:
350
–365,
2003
12.
Innes KE, Vincent HK, Taylor AG: Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part I: neurophysiological responses and pathological sequelae.
Alt Ther Health Med
13
:
46
–52,
2007
13.
Baumann H, Gauldie J: The acute phase response.
Immunol
15
:
74
–80,
1994
14.
Lazar SW, Bush G,Gollub RL, Fricchione GL, Khalsa G, Benson H: Functional brain mapping of the relaxation response and meditation.
Neurorep
11
:
1581
–1585,
2000
15.
ABC's of Yoga, MaxLifestyle International Inc.: The endocrine system (glands) and yoga [article online]. Available from http://www.abc-of-yoga.com/health/glands.asp. Accessed 26 June 2008
16.
Liu X, Miller YD,Brown WJ: A qualitative review of the role of qi gong in the management of diabetes.
J Alt Complement Med
13
:
427
–433,
2007
17.
Rosenzweig S,Reibel DK, Greeson JM, Edman JS, Jasser SA, McMearty KD, Goldstein BJ:Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study.
Alt Ther Health Med
13
:
36
–38,
2007
18.
Elder C, Aickin M,Bauer V, Cairns J, Vuckovic N: Randomized trial of a whole-system ayurvedic protocol for type 2 diabetes.
Alt Ther Health Med
12
:
24
–30,
2006
19.
McGinnis RA,McGrady A, Cox SA, Grower-Dowling KA: Biofeedback-assisted relaxation in type 2 diabetes.
Diabetes Care
28
:
2145
–2149,
2005
20.
van Rooijen AJ,Rheeder P, Eales CJ, Becker PJ: Effect of exercise versus relaxation on haemoglobin A1C in Black females with type 2 diabetes mellitus.
Quart J Med
97
:
343
–351,
2004
21.
Surwit RS, van Tilburg MAL, Zucker N, McCaskill CC, Parekh P, Feinglos MN, Edwards CL,Williams P, Lane JD: Stress management improves long-term glycemic control in type 2 diabetes.
Diabetes Care
25
:
30
–34,
2002
22.
U.K. Prospective Diabetes Study Group:Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control(UKPDS 37).
Diabetes Care
22
:
1125
–1136,
1999
23.
Stenstrom U, Goth A, Carlsson C, Andersson P: Stress management training as related to glycemic control and mood in adults with type 1 diabetes mellitus.
Diabetes Res Clin Pract
60
:
147
–152,
2003
24.
Jablon SL,Naliboff BD, Gilmore SL, Rosenthal MJ: Effects of relaxation training on glucose tolerance and diabetic control in type II diabetes.
Appl Psychophysiol Biofeedback
22
:
155
–169,
1997